Investor Relations
Mar 21, 2019
OPKO Announces Positive Topline Results In Phase 2 Diabetes And Obesity Trial MORE >>
Feb 27, 2019
OPKO Health Reports 2018 Fourth Quarter Business Highlights and Financial Results MORE >>
Feb 26, 2019
OPKO Health to Announce Fourth Quarter 2018 Financial Results on February 27, 2019 MORE >>
Feb 05, 2019
OPKO Health, Inc. Announces the Pricing of its Offering of Convertible Senior Notes MORE >>

SEC Filing Details

Document Details

Filing Date
Sep 30, 1998
Document Date
Sep 30, 1998
Form Description
Post-effective amendment to an S-Type filing
Filing Group
Registration Statements
Company
OPKO Health, Inc.